Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 9
2004 14
2005 21
2006 20
2007 23
2008 15
2009 24
2010 29
2011 25
2012 36
2013 36
2014 42
2015 48
2016 33
2017 51
2018 50
2019 66
2020 74
2021 76
2022 82
2023 70
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

767 results

Results by year

Filters applied: . Clear all
Page 1
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).
Zhao WH, Wang BY, Chen LJ, Fu WJ, Xu J, Liu J, Jin SW, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Zhang H, Bai J, Xu Y, Zhu H, Du J, Jiang H, Fan XH, Li JY, Hou J, Chen Z, Zhang WG, Mi JQ, Chen SJ, He AL. Zhao WH, et al. J Hematol Oncol. 2022 Jul 6;15(1):86. doi: 10.1186/s13045-022-01301-8. J Hematol Oncol. 2022. PMID: 35794616 Free PMC article. Clinical Trial.
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.
Zhao WH, Liu J, Wang BY, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Yang N, Zhang R, Zhang H, Shen Y, Bai J, Xu Y, Wang XG, Zhang RL, Wei LL, Li ZF, Li ZZ, Geng Y, He Q, Zhuang QC, Fan XH, He AL, Zhang WG. Zhao WH, et al. J Hematol Oncol. 2018 Dec 20;11(1):141. doi: 10.1186/s13045-018-0681-6. J Hematol Oncol. 2018. PMID: 30572922 Free PMC article. Clinical Trial.
HSF1 promotes CD69+ Treg differentiation to inhibit colitis progression.
Yu L, Zhou B, Zhu Y, Li L, Zhong Y, Zhu L, Wang H, Chen H, Xu J, Guo T, Feng L, Wang X, Cai Z, Wang J, Jin H. Yu L, et al. Among authors: wang j. Theranostics. 2023 Mar 21;13(6):1892-1905. doi: 10.7150/thno.78078. eCollection 2023. Theranostics. 2023. PMID: 37064870 Free PMC article.
767 results